|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,036.00 GBX | +2.52% |
|
-8.36% | -12.72% |
| 02:14pm | Markets Drift Gently Towards the Mid-August Lull |  |
| 10:18am | US FDA approves first mRNA flu shot from Moderna | RE |
| Market Cap | 251B 218B 203B 187B 352B 23,905B 356B 2,385B 936B 11,961B 944B 923B 39,613B | P/E 2026 * |
20.9x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 271B 235B 219B 202B 381B 25,815B 385B 2,576B 1,011B 12,916B 1,020B 997B 42,778B | EV / Sales 2026 * |
4.29x | EV / Sales 2027 * | 3.95x |
| Free-Float |
96.63% | Yield 2026 * |
2.05% | Yield 2027 * | 2.18% |
Last Transcript: AstraZeneca PLC
| 1 day | +2.52% | ||
| 1 week | -8.36% | ||
| Current month | -4.72% | ||
| 1 month | -16.74% | ||
| 3 months | -9.71% | ||
| 6 months | -13.91% | ||
| Current year | -12.72% |
| 1 week | 11,414 |  | 12,894 |
| 1 month | 10,524 | | 14,478 |
| Current year | 10,524 | | 15,732 |
| 1 year | 10,524 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,029 | | 15,732 |
| 10 years | 3,996 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/7/26 | Free | See Remarks | 2 | 0.0000% | ||
| 22/12/25 | Sell | Director | 297 | 0.0000% | ||
| 19/12/25 | Don | Director | 5,735 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.52% | -8.36% | +7.27% | +10.32% | 251B | |
| +4.86% | -3.32% | +52.73% | +160.26% | 1,043B | |
| +1.04% | -2.99% | +50.87% | +52.38% | 621B | |
| +0.98% | -6.49% | +24.00% | +66.66% | 435B | |
| +1.96% | +0.83% | +42.80% | +37.60% | 361B | |
| -0.11% | -4.07% | +30.37% | +39.73% | 293B | |
| +4.57% | +5.21% | +35.91% | +67.64% | 220B | |
| -4.32% | -12.94% | -3.79% | -44.56% | 201B | |
| -2.58% | -0.73% | +17.16% | +67.46% | 164B | |
| +1.57% | +2.62% | +4.28% | -26.30% | 147B | |
| Average | +0.31% | -3.37% | +26.16% | +43.12% | 373.62B | |
| Weighted average by Cap. | +0.68% | -3.61% | +35.81% | +72.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.27B 54.8B 51.08B 46.98B 88.7B 6,016B 89.69B 600B 236B 3,010B 238B 232B 9,970B | 66.85B 57.9B 53.97B 49.64B 93.71B 6,357B 94.76B 634B 249B 3,181B 251B 246B 10,534B |
| Net income | 12B 10.39B 9.69B 8.91B 16.82B 1,141B 17.01B 114B 44.67B 571B 45.06B 44.07B 1,890B | 13.64B 11.82B 11.02B 10.13B 19.13B 1,297B 19.34B 129B 50.81B 649B 51.25B 50.12B 2,150B |
| Net Debt | 20.09B 17.4B 16.22B 14.91B 28.16B 1,910B 28.47B 191B 74.79B 956B 75.44B 73.77B 3,165B | 12.78B 11.07B 10.32B 9.49B 17.91B 1,215B 18.11B 121B 47.58B 608B 47.99B 46.93B 2,013B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | GBX 12,036.00 | +2.52% | 6,337,651 |
| 04/08/26 | GBX 11,740.00 | +2.09% | 7,393,774 |
| 03/08/26 | GBX 11,500.00 | -8.96% | 13,543,538 |
| 31/07/26 | GBX 12,632.00 | -0.69% | 1,904,551 |
| 30/07/26 | GBX 12,720.00 | -3.15% | 5,166,279 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
